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Purpose: Aorto-bifemoral bypass (AFB) is commonly performed in US hospitals. Durable long-term outcome is achieved
after AFB performed to treat aortoiliac occlusive disease. However, short-term outcome for complex surgical procedures
is not uniform across medical centers. The objective of the current study was to define the relationship of hospital volume
to operative mortality after AFB.
Methods: The study included 3073 patients with a primary procedure code for AFB and a diagnostic code for peripheral
vascular occlusive disease who received treatment during 1997 at 483 hospitals in the Nationwide Inpatient Sample
(NIS). The NIS represents a 20% stratified random sample representative of all US hospitals. Unadjusted and case
mix–adjusted analyses were performed.
Results: Overall AFB-related mortality was 3.3%. Hospitals that performed more than 25 AFB per year (33% of patients
at 37 hospitals in the NIS) had a lower crude mortality rate (3.7% vs 2.2%) compared with hospitals that performed fewer
AFB. In a multivariate analysis adjusting for case mix, AFB at a high- volume hospital was associated with 42% decreased
risk for in-hospital mortality (odds ratio [OR], 0.58; 95% confidence interval [CI], 0.34-0.97; P  .04) compared with
low-volume hospitals. Two other important risk factors associated with increased mortality in the multivariate analysis
included age more than 65 years (OR, 3.3; 95% CI, 2.0-5.4) and history of chronic pulmonary disease (OR, 1.9; 95% CI,
1.2-2.9).
Conclusions: AFB operative mortality was significantly lower at high-volume hospitals in this nationally representative
database. The effect of hospital volume of AFB procedures on outcome should be of importance to patients, providers,
and health policy makers. (J Vasc Surg 2003;37:970-5.)
Aorto-bifemoral bypass (AFB) is performed commonly
in US hospitals, with durable long-term outcome in pa-
tients with aortoiliac occlusive disease.1,2 However, short-
term outcome for complex surgical procedures varies across
medical centers.3-5 For several other complex vascular,
cardiac, and general surgical procedures, high hospital vol-
ume is associated with improved outcome.3-9 Previous
population-based studies have combined AFB with other
lower extremity bypass procedures associated with much
lower operative mortality.8,9 Therefore, little specific infor-
mation is available regarding effect of hospital volume on
short-term outcome for AFB.
Currently, health policy initiatives suggest regionaliza-
tion of certain vascular procedures, including abdominal
aortic aneurysm (AAA) repair and carotid endarterecto-
my.10,11 AFB is commonly performed, and, given the
complexity of the procedure, it is plausible that surgeons
with more experience with the operation will produce
superior outcome, similar to other high-risk operations.
The objective of the present study was to define the rela-
tionship of volume to AFB-related mortality with a nation-
ally representative database.
METHODS
Data source. Data for patients who had undergone
AFB were abstracted from a nationally representative hos-
pital discharge database, the Nationwide Inpatient Sample
(NIS). The NIS is a 20% random sample of all hospital
discharges in the United States, stratified by geographic
region, urban or rural location, teaching status, ownership,
and bed size, in an effort to create a representative sample of
the nation’s hospitals. The data are maintained by the
Agency for Health Care Policy and Research as part of the
Healthcare Cost and Utilization Project database.12 Data
for the present study were derived from the 1997 version of
the NIS.
All adult patients who underwent treatment in 1997
who had an International Classification of Diseases, Ninth
Revision, Clinical Modification primary procedure code for
ABF (ICD-9-CM code 3925) were initially identified.13 To
study only the population of patients who underwent sur-
gery to treat aortoiliac occlusive disease, those patients
undergoing AFB with a primary diagnostic code of AAA
were excluded (ICD-9-CM code 4414 or 4413). Second-
ary ICD-9-CM diagnostic codes were abstracted to ascer-
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tain the presence of several comorbid diseases.14,15 Data
regarding age, sex, race, nature of admission, comorbid
diseases, in-hospital mortality, and length of stay (LOS)
were abstracted directly from the database for all patients.
Provider variables. The number of procedures per-
formed at each hospital during 1997 was calculated with an
anonymous hospital identification number available in the
NIS database. Hospitals were categorized as high volume
or low volume on the basis of a predetermined cutoff point
at the 66th percentile of volume. With these criteria, high-
volume hospitals performed more than 25 procedures dur-
ing the 1-year study. This volume threshold was compared
with previous studies of AAA conducted with state admin-
istrative databases.3-11 Hospital volume rather than indi-
vidual surgeon volume or surgeon specialty was used as the
provider variable of choice, because the NIS lacks complete
data on surgeon identifiers and has no information on
surgeon specialty. Further, provider-level variables tend to
be collinear and cannot simultaneously be analyzed with
multivariate analysis.
Outcome variables. In-hospital mortality was the
primary end point. Prolonged LOS was a secondary end
point, used to compare relative use of resources between
high-volume and low-volume hospitals. Prolonged LOS
was taken as greater than the 75th percentile, and a dichot-
omous variable was created. Such analysis will allow study
of outlier patients, as opposed to use of nonparametric
statistics, which takes emphasis from this group of patients.
Statistical analysis. Univariate comparisons of hospi-
tal volume, patient characteristics, and outcome variables
were performed with the 2 test, Wilcoxin rank-sum test,
Student t test, simple logistic regression, and simple linear
regression, where appropriate. The Romano modification
of the Charlson comorbidity score was used with ICD-
9-CM codes from an index hospitalization to account for
comorbid diseases.14,15 The Romano-Charlson index was
treated as a categorical variable, and patients were classified
according to number of comorbid diseases (0, 1, 2, or3).
Multiple logistic regression of in-hospital mortality and
prolonged LOS was used to test their association with
hospital volume after adjusting for potentially confounding
patient case mix variables. The multivariate model of mor-
tality was tested for goodness of fit according to the Hos-
mer-Lemeshow method, and the area under the receiver
operator characteristic (ROC) curve was calculated. Any
patient characteristic that had a P value .1 at univariate
analysis was included in the multivariate analysis. P .05
was considered statistically significant in all final analyses.
STATA Version 7.0 (College Station, Tex) was used for all
statistical analyses.
RESULTS
Hospital and patient characteristics. AFB was per-
formed in 3073 patients to treat aortoiliac occlusive disease,
in 483 hospitals from 22 states, reported in the 1997 NIS.
Of the sample of hospitals, 37 (8%) were high-volume
hospitals and 446 (92%) were low-volume hospitals. Pa-
tients at high-volume and low-volume hospitals had gener-
ally similar demographic characteristics and relative burden
of comorbid disease, with certain exceptions (Table I).
Patients in high-volume hospitals were more likely to un-
dergo urgent or emergent procedures compared with those
in low-volume hospitals. Type of insurance and median
income were similar between patients undergoing surgery
at high-volume and low-volume hospitals.
In-hospital mortality rate. Overall AFB mortality
was 3.3%, with extensive geographic variation noted across
the 22 states in the sample. For example, mortality varied
from 0% in hospitals from 4 states (Ariz, Colo, Conn,
Wash) to 7.1% in selected hospitals from 2 other states
(Md, Utah). Increasing patient age was also an important
predictor of death, with mortality varying from 1.3% for
patients younger than 50 years to 10.4% for patients older
than 80 years. Increasing mortality was noted with elective
(2.9%), urgent (4.0%), and emergent (4.6%) AFB.
Hospital volume was initially divided into 3 groups on
the basis of terciles of hospital AFB volume. However, low
AFB volume (10/y) and medium AFB volume (11-
25/y) yielded similar mortality (3.5% vs 3.8%) and were
combined for further analyses. Hospital volume was there-
fore a dichotomous variable with low volume (25/y) and
high volume (25/y). Hospitals that performed more
than 25 procedures per year (33% of patients at 37 hospitals
from the NIS) had a lower crude mortality rate (3.7% vs
2.2%), a difference that persisted for both older and
younger patients (Fig 1). The difference in AFB mortality
between high-volume and low-volume hospitals was more
significant for patients who were younger than 65 years
(0.7% vs 2.1%; P .04) compared with those who were 65
years old or older (4.6% vs 5.7%; P  .40) (Fig 1). History
of chronic obstructive pulmonary disease (COPD) was
associated with marked increase in risk for death (2.7% vs
4.9%). When analyzed across hospital volume categories,
mortality rate was reduced more in patients with COPD at
high-volume hospitals (2.5% vs 6.9%; P  .03) compared
with patients without COPD (2.4% vs 2.9%; P .4) (Table
II). Patients with COPD, independent of age, had lower
mortality at high-volume hospitals compared with low-
volume hospitals (Fig 2; Table II).
At multivariate analysis adjusting for case mix, under-
going surgery at a high-volume hospital was associated with
a 42% decreased risk for in-hospital death (odds ratio [OR],
0.58; 95% confidence interval [CI], 0.34-0.97; P  .04)
(Table III). In addition, two other important risk factors in
multivariate analysis include age 65 years or older (OR, 3.3;
95% CI, 2.0-5.4) and history of chronic pulmonary disease
(OR, 1.9; 95% CI, 1.2-2.9).
Length of stay. Overall median LOS was 7 days
(interquartile range, 5-9 days). Prolonged LOS was greater
than the 75th percentile, which was 9 days. There was no
difference in proportion of patients with prolonged LOS at
high-volume hospitals (24%) versus low-volume hospitals
(25%) (P  .30). The most significant predictor of pro-
longed LOS was age 65 years or older. Patients 65 years old
or older required prolonged LOS during 32% of admissions
versus 19% for patients younger than 65 years (P .001).
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At multivariate analysis, independent variables associated
with increased risk for prolonged LOS included age 65
years or older (OR, 2.3; 95% CI, 1.9-2.8), urgent admis-
sion (OR, 1.4; 95% CI, 1.4-2.4), emergent admission (OR,
4.4; 95% CI, 3.2-6.1), chronic pulmonary disease (OR,
1.5; 95% CI, 1.2-1.9), and nonwhite race (OR, 1.6; 95%
CI, 1.2-2.3).
DISCUSSION
Payers, providers, and patients are increasingly con-
cerned with quality of health care in the United States.16,17
Some patients receive high-quality care and achieve desired
health care outcome, with a high level of satisfaction.
However, not all patients receive the same high quality of
care, creating a gap between quality of care actually pro-
vided and quality of care that could be provided.16,17
Patient outcome is a particularly useful measure of quality
of surgical care, because its importance is readily apparent
to all stakeholders. Given the complexity of surgery and the
high rate of mortality and complications attending certain
procedures, comparing outcomes is a feasible method for
assessing quality. The current study demonstrates an asso-
ciation between increasing hospital volume and improved
outcome of AFB. Specifically, patients undergoing AFB at
high-volume hospitals had a 42% decreased risk for opera-
tive death compared with those operated on at low-volume
hospitals.
In terms of absolute risk reduction, the adjusted abso-
lute difference between high and low volume centers is
1.5%, yielding a number needed to treat 65 patients. In
other words, 65 patients would need to be referred to a
high-volume center to prevent 1 death. However, referring
patients to high-volume centers is not the only benefit of
documenting the effect of volume on outcome for AFB.
For instance, if structure and process variables that lead to
improved outcome at high-volume centers can be deter-
mined, they can be used to guide quality improvement at
low-volume centers, thereby improving care at all hospitals.
Previous observational studies have documented a re-
lationship between increasing provider volume and im-
proved outcome for complex surgical procedures.3-9 The
relationship between volume and outcome specifically for
AFB has not previously been investigated. Earlier popula-
tion-based studies documented a small effect of volume on
outcome for lower extremity arterial bypass procedures,
including both AFB and infrainguinal bypass.8,9 For exam-
ple, in a recent study by Birkmeyer et al9 from the Medicare
population, mortality varied from 5.9% at low-volume hos-
pitals to 4.8% at high-volume hospitals, with an adjusted
risk reduction of 22% (OR, 0.78; 95% CI, 0.72-0.85).
However, AFB places the patient at higher risk for adverse
outcome, because the magnitude of the operation is greater
than that of other lower extremity bypass procedures;
therefore AFB should be analyzed separately. Several pub-
lished reports have shown the volume-outcome effect for
AAA repair.3-9 In fact, AAA repair is one of five surgical
procedures the Leapfrog group has recommended for re-
gionalization.11 AFB is a common, high-risk surgical pro-
cedure that should also be considered for regionalization,
given the magnitude of the volume-outcome effect ob-
served in the present investigation.
Given the differences in mortality associated with vol-
ume and the extensive geographic variation, attention is
needed to provide uniform level of high-quality care to
Table I. Characteristics of patients undergoing aorto-bifemoral bypass at high-volume and low-volume hospitals
Patient characteristics
High-volume hospitals* Low-volume hospitals
n % n %
Total number of patients 995 32 2085 68
Age (y) (mean  SD) 63  11 63  10
Female gender 474 48 969 47
Nonwhite race 87 11 200 12
Elective admission 589 68 1,416 78†
Urgent admission 186 22 167 15†
Emergent admission 92 11 129 7†
Comorbidity index
0 354 36 784 38
1 372 38 827 40
2 192 19 359 17
3 77 8 115 6
Insurance
Medicare 526 53 1009 49
Private 367 37 818 39
Medicaid 64 6 136 7
Median income by ZIP code
$1-$24,999 266 29 634 32
$25,000-$34,999 221 24 440 22
$35,000-$44,999 144 16 353 18
$45,000 292 32 534 27
*More than 25 procedures per year.
†Comparison of high-volume with low-volume hospitals: P  .05, or Wilcoxon rank-sum test.
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patients in need of AFB. Several options are available to
improve quality of care in this setting. First, patients may be
selectively referred to high-volume hospitals. Second, the
structure and process at high-volume hospitals could be
studied and used to guide quality improvement efforts at
low-volume hospitals. Third, as an alternative to imposing
volume standards, providers can report risk-adjusted out-
come, and patients can be selectively referred to hospitals
with low risk-adjusted mortality rates. This last option
requires a large commitment of resources and effort on the
part of health care providers. Consequently, until direct
comparisons of quality are available, patients should seek
referral to a high-volume institution.
When the current study was performed, iliac artery
stenting was not widely available for treatment of aortoiliac
occlusive disease, and most patients underwent AFB. Over
the last several years the overall number of AFB performed
has decreased, and the volume threshold may also have
changed. However, the goal of the current study was not to
generate a single number that drives health policy but
simply to demonstrate that short-term outcome after AFB
is not uniform across medical centers. Mortality after AFB
varies among providers, with higher volume providers, in
general, having superior outcome. Given recent changes in
the approach to treatment of symptomatic aortoiliac occlu-
sive disease, there may be changes in the performance
profile of surgeons. However, the concept of a volume-
outcome relationship for AFB likely will not change.
Most studies on the effect of volume on outcome,
including the current report, rely on use of administrative
data and are therefore subject to certain limitations. Such
data do not allow for physiologic or detailed clinical risk
adjustment.18 However, no data suggest that patients un-
dergoing surgery at low-volume hospitals are sicker than
patients undergoing surgery at high-volume hospitals. On
Fig 1. In-hospital mortality (%) at high-volume and low-volume
hospitals for patients younger than 65 years and for those 65 years
old or older. Mortality rate is decreased at high-volume hospitals
for both age groups, but is of greater absolute magnitude and
reaches statistical significance for younger patients. *P  .05.
Fig 2. In-hospital mortality (%) at high-volume and low-volume
hospitals for patients with and without chronic obstructive pulmo-
nary disease (COPD). Mortality rate is substantially decreased in
high-volume hospitals for patients with a history of COPD, with a
much smaller difference for patients without COPD. *P  .05.
Table II. Mortality rate after aorto-bifemoral bypass






Without COPD overall 2.4 2.9
Age 65 y 0.9 1.8
Age 65 y 4.4 4.4
With COPD overall 2.5 6.9
Age 65 years 0 3.1
Age  65 years 4.8 8.8
COPD, Chronic obstructive pulmonary disease.
*More than 25 procedures per year.
Table III. Results of multivariate analysis: independent






High-volume hospital* 0.58 0.34 to 0.97 .039
Female gender 1.3 0.83 to 2.0 .24
Urgent admission 1.4 0.81 to 2.4 .22
Emergent admission 1.7 0.87 to 3.5 .12
COPD 1.9 1.2 to 2.9 .006
Age 65 y 3.3 2.0 to 5.4 .001
OR, Odds ratio; CI, confidence intervals; COPD, chronic obstructive pul-
monary disease.
*More than 25 procedures per year.
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the contrary, in the current sample, patients more often
underwent urgent or emergent surgery at high-volume
hospitals than at low-volume hospitals.
In conclusion, the results of the current study demon-
strate that high-volume hospitals yield superior outcome
for AFB than do low-volume centers. Without other infor-
mation regarding quality of surgical care for patients in
need of AFB, referral to a high-volume center can result in
superior outcome. However, referring patients to high-
volume centers is only one benefit of recognizing a volume-
outcome effect for AFB. If the structure and process vari-
ables that lead to improved outcome at high-volume
centers can be determined, they can be used to guide
quality improvement at low-volume centers, thereby im-
proving care at all hospitals. Future investigations should
focus on determining the structure and process variables
associated with improved outcome at high-volume hospi-
tals. Given the variation in quality of surgical care, feasibility
of direct comparison of quality based on risk-adjusted
outcome measures should also be thoroughly explored.
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DISCUSSION
Dr Gregorio Sicard (St Louis, Mo). I would like to thank Dr
Dimick for bringing this interesting manuscript to us and for
sending it to me for review ahead of time. I think this contribution
adds to a growing literature of the association between volume of
procedures performed with outcomes.
One of the problems with looking at national data is the
accuracy of the data. Even though a significant number of your
patients were not covered under Medicare health coverage, its data
has been established to have about a 22% error rate in the actual
coding. In the database that you used, has the accuracy of the data
been corrected? Has it been looked at in terms of precision of
coding for both high- and low-volume hospitals?
Also, were you able to correlate the volume, the outcomes,
and volumes to the type of hospital? In other words, are they
high-volume hospital training centers? Do they have residents,
advanced ICU care, critical care residency programs that increase
significantly the quality of care?
How about the mortality? When you looked at mortality, was
hospital mortality reported associated with one admission or was it
30-day mortality? In this national data, did the patient get a
different number for each admission?
Also, have you had a chance to look. . .I know there is in the
cardiological literature the correlation between volume and com-
plications associated with coronary interventions. Have you had a
chance to look at. . .does this database that you are using have
endovascular treatment information, because aortoiliac disease is
being treated less with aorto-bifemoral bypass graft, and it may be
that you are looking now at low-volume hospitals that are doing an
operation that may not be the current standard of care.
Thank you.
Dr Justin Dimick. Thank you, Dr Sicard. Starting with your
first question regarding the accuracy of this database, administra-
tive databases are not as accurate as a similar clinical database.
However, the error rate you stated for the Medicare database with
DRG coding is across all conditions. Luckily, as surgeons we can
query by the single ICD-9 code that captures the primary proce-
dure related to that hospitalization. It is actually incredibly accu-
rate in pulling out patients who had that specific operation, and is
generally quoted as being less than 2% to 5% error for the primary
procedure coding. That is how we selected our patients, so we
believe it is very accurate.
Where it is not as accurate is in coding of comorbid conditions.
A clinical database would provide more robust risk adjustment.
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However, you would not be able to use this sort of analysis with a
clinical database because the ones that do exist are either a single
center or have voluntary reporting, and only those people you
would be worried about, people being involved who have the best
outcomes.
In answer to your second question regarding the impact of
teaching hospital status, we do have that data. We have not
included that in this analysis. We are actually working on that now
for several surgical procedures, looking at the impact of teaching
hospital status on outcome as well as the interaction of volume and
teaching status. We do not know whether or not these hospitals
had ICUs, and there are data out there showing that having a
board-certified intensivist improves your outcomes for abdominal
aortic operations. Such things as ICU staffing and other structural
variables are probably the things that really make the difference at
high-volume hospitals. As I stated in my conclusion, I think
studying and determining what those factors are will allow us to
improve outcomes at low-volume hospitals.
In answer to your question about endovascular techniques,
these were all open operations, and at the time these were done,
this was 1997, there was very little endovascular surgery being
done. I think as the administrative data matures we will have the
ability to look at the relative utilization and effectiveness of endo-
vascular versus open procedures. The problem is, the administra-
tive databases, especially national administrative databases, lag
several years behind clinical activity, and we will have to wait for
that to become available.
Dr John Blebea (Hershey, Pa). I enjoyed your presentation,
and have two questions. You mentioned the Charlson index as a
measure of comorbid conditions and illness severity, but was that
included in your multivariate analysis? I noted the other clinical
factors examined as variables, but did not see the index as an
independent variable or used to stratify the patients.
Dr Dimick. The Romano-Charlson index is essentially 10
comorbid diseases, and the way you analyze the database varies
from report to report. The way we did it was to enter each
individual comorbid disease as a separate entity into the multivar-
iate analysis, and in this analysis, chronic obstructive pulmonary
disease, which is one disease in the index, fell out as being signifi-
cant.
Dr Blebea. I presume, therefore, that if you separated them
individually, the numbers for some of these variables were poten-
tially too small to statistically quantify them as significant? Another
potential problem, if you are looking at the clinical variables
individually, is that a particular single variable may randomly come
out to appear significant. You could utilize the index as a single
discriminating variable and not lose the potential correlation be-
tween overall illness severity and clinical outcomes.
Dr Dimick. I agree, and that is why we separated it out into
multiple diseases. I used the index here to present. . . just to
simplify it, rather than listing the 10 diseases, because there were
very few differences between centers or there were no significant
differences between high- and low-volume hospitals.
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